10 Pfizer finance leaders
Spread across several markets, these Pfizer finance leaders include CFOs for Pfizer Japan, Pfizer Ltd, Australia and New Zealand, and Mexico and Central America, a Paris-based deputy CFO, a CFO Pharmaceuticals and four finance vice presidents, among them R&D finance, global business services and North America. Nine hold their Pfizer roles today. They suit a call on running finance for one country, planning R&D spend or running record to report in shared services.
Professionals to explore
Akiyoshi Motoyama
LinkedInExperience: Corporate Officer & CFO at Pfizer Japan Inc. · Pfizer
Akiyoshi Motoyama has been Corporate Officer & CFO at Pfizer Japan Inc. since March 2020. Akiyoshi Motoyama's other Pfizer titles are Senior Director, Japan Biopharma Finance Lead & HBU Developed Asia Cluster Finance Lead (2019-2020), Senior Director, Japan Biopharma Finance Lead (2017-2018), Director, Japan PEH Finance Lead (2016-2017) and Director, Japan Internal Audit Lead (2014-2016), so country finance and audit in Japan are the strongest topics.
Is this you? Claim your profile and get paid for calls.
Amit Agarwal
LinkedInExperience: Executive Director Finance & Chief Financial Officer, Pfizer Ltd · Pfizer
Amit Agarwal, based in Mumbai, has held Executive Director Finance & Chief Financial Officer, Pfizer Ltd since February 2024. At Unilever, Amit Agarwal was General Manager Finance - Sales & Customer Development (2022-2024), General Manager - Internal Audit (2020-2022) and Finance Controller - Global Business Services (2016-2020), which makes comparing CFO work at Pfizer Ltd with Unilever finance a good use of a call.
Is this you? Claim your profile and get paid for calls.
Blakeley Maggi
LinkedInExperience: Vice President, R&D Finance, FP&A and Business Innovation · Pfizer
Since February 2026, Blakeley Maggi has been Vice President, R&D Finance, FP&A and Business Innovation at Pfizer, and held Sr. Director, R&D Finance - FP&A and Finance Operations (2021-2026), Sr. Finance Director, Global Product Development FP&A (2014-2021), Finance Director, Oncology Business Unit (2012-2014) and Senior Manager Finance, Oncology Business Unit (2010-2012) there. R&D planning and forecasting are the clear topics.
Is this you? Claim your profile and get paid for calls.
Bradley Apps
LinkedInExperience: Pfizer Aust & NZ Finance Director CFO and Cluster Lead Finance Market Ops ANZ, Japan, Korea & Canada · Pfizer
Bradley Apps's current title is Pfizer Aust & NZ Finance Director CFO and Cluster Lead Finance Market Ops ANZ, Japan, Korea & Canada (since December 2020). Bradley Apps also held Finance Director CFO, ANZ & Korea (2016-2020), Head of Business Finance, ANZ (2015-2016), Commercial SAP Project Lead ANZ (2014-2015) and Head of Finance, Biopharma and Primary Care ANZ (2008-2014) at Pfizer, a fit for multi-country cluster finance questions.
Is this you? Claim your profile and get paid for calls.
Brian Martin
LinkedInExperience: Vice President, Finance & Global Business Services - US Site Lead & Global Record to Report Leader · Pfizer
Brian Martin is Vice President, Finance & Global Business Services - US Site Lead & Global Record to Report Leader at Pfizer (since November 2020), responsible for a global team delivering finance, accounting, financial reporting and risk management activities. Brian Martin was also Vice President & US Site Lead, Global Financial Services (2014-2020) and Director Record to Report Operations - Global Financial Solutions (2010-2014) at Pfizer, and Senior Vice President & Chief Financial Officer at Kilmar Capital LLC (2004-2010).
Is this you? Claim your profile and get paid for calls.
George Henninger
LinkedInExperience: CFO Pharmaceuticals · Pfizer
George Henninger holds the current title CFO Pharmaceuticals at Pfizer, a C-level finance role. Among these ten, George Henninger is the one whose title points to finance for Pfizer's pharmaceuticals business as a whole rather than a single country, region or function, so business-wide finance questions fit best.
Is this you? Claim your profile and get paid for calls.
Kathleen Riley-Brown
LinkedInExperience: Former Vice President Finance, North America · Pfizer
Kathleen Riley-Brown was Vice President Finance, North America at Pfizer from 2002 to 2006, a role in which Kathleen Riley-Brown functioned as chief financial officer of a $2.3B North America business as a member of the PCH NA Leadership Team. Kathleen Riley-Brown also held Senior Director, Financial Planning, Reporting & Analysis (2000-2002), Finance Manager (1986-1987) and Auditor roles at Pfizer, a fit for questions on finance in that period.
Is this you? Claim your profile and get paid for calls.
Marina Capay
LinkedInExperience: Deputy Chief Financial Officer · Pfizer
Marina Capay has been Deputy Chief Financial Officer, Pfizer Paris, since October 2020, a role responsible for managing and coordinating financial planning, the execution of business strategies, and treasury and cash management. Marina Capay has also been a Member Board of Directors at ReViral since July 2018, so deputy CFO work at Pfizer Paris and treasury questions fit.
Is this you? Claim your profile and get paid for calls.
Omar Gomez
LinkedInExperience: Director financiero · Pfizer
Omar Gomez holds Director financiero at Pfizer (since November 2018), serving as CFO for Pfizer Mexico & Central America, after Controller at Pfizer (2008-2018). Omar Gomez was Accounting Supervisor at Cargill (2003-2008) and Senior Auditor at EY (2002-2003), so controllership and finance for Mexico and Central America are the natural topics.
Is this you? Claim your profile and get paid for calls.
Toni King
LinkedInExperience: Sr Vice President, Finance · Pfizer
Toni King has held Sr Vice President, Finance at Pfizer since January 2020, an executive-level finance title. Because the title doesn't name a single area of finance, Toni King is best asked broad questions on senior finance work at Pfizer rather than about a specific business or country.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For running finance in a single market, start with Akiyoshi Motoyama, Amit Agarwal, Bradley Apps or Omar Gomez, or Marina Capay for the deputy CFO view. Blakeley Maggi is the pick for R&D planning and Brian Martin for record to report and shared services; Toni King holds a broad finance title that doesn't name a single business or country, George Henninger is CFO Pharmaceuticals, and Kathleen Riley-Brown speaks to North America finance up to 2006.
Questions to take into the conversation
- 01How does a Pfizer country CFO split time between local market targets and the corporate planning and reporting calendar?
- 02How is R&D spending forecast and re-planned at Pfizer when pipeline priorities shift mid-year?
- 03Which finance processes sit in Pfizer's global business services, and which stay with country finance teams?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.